View Cart  

March 28, 2005

Vol. 2 No. 61

View Archived Issues

Sign Up Now

Jury Rules Against Boston Scientific

Boston Scientific's NIR stent -- a device designed and manufactured by Israel-based Medinol that Boston Scientific no longer markets or sells -- was found to infringe upon a single claim of Johnson & Johnson's (J&J's) Palmaz patent, a Delaware jury ruled.

Read More

AngioScore Announces Completion of Catheter Trial

AngioScore, a developer of angioplasty tools for interventional cardiologists and radiologists, announced the completion of the U.S. clinical trial for its AngioSculpt Scoring Balloon Catheter in coronary lesions and the conclusion of follow-up on the 200 patients in the trial.

Read More

FDA Approves Kensey Nash's TriActiv System

Medical devicemaker Kensey Nash has received clearance from the FDA to sell its TriActiv System in the U.S., and will launch the product through its new direct sales force.

Read More

Nanogen Issued Patent for Electronic Microarray With Memory

Nanogen, a developer of advanced diagnostic products, has been issued U.S. Patent No. 6,867,048, "Multiplexed Active Biologic Array" by the U.S. Patent and Trademark Office.

Read More

J&J, Guidant Merger Registration Declared Effective

Johnson & Johnson (J&J) and Guidant announced that the SEC has declared effective the S-4 Registration Statement concerning their planned merger.

Read More

Tyco Unit to Appeal Antitrust Verdict

The Nellcor unit of Tyco International said that it would appeal a $420 million award that it was ordered to pay for engaging in anticompetitive behavior in the market for machines that measure the oxygen content in blood.

Read More

Biomarker to Begin Study of a New Blood Test for Breast Cancer

Biomarker Technologies, the worldwide technology provider of the blood diagnostic test for the detection of breast cancer called the BT Test, announced plans to begin a pilot study of the test in the U.S. beginning in April 2005.

Read More

Alcon Gains Approval for Cataract Lens

Fort Worth, Texas-based Alcon has won government approval for the latest generation of its intraocular lens for cataract patients, the company announced.

Read More

Eye Dynamics Signs Letter of Intent to Acquire OrthoNetx

Eye Dynamics, a leading of health and safety products, announced it has signed a letter of intent to acquire Superior, Colorado-based OrthoNetx, a provider of medical devices for osteoplastic surgery.

Read More

Dade Behring Gets New Credit Line

Medical-test maker Dade Behring Holdings said it will enter into a new, multiyear agreement with a consortium of banks to provide a $600 million revolving credit facility for the company.

Read More

HealthTronics Completes $175 Million Refinancing

HealthTronics announced that it signed a new $125 million Senior Secured Term Loan B, due 2011, and a definitive credit agreement for a new five-year $50 million revolving credit facility, due 2010.

Read More

UM to Compare Effectiveness of Powerheart With Traditional Protocol

Cardiac Science announced that physicians at the University of Michigan (UM) Cardiovascular Center have launched a prospective study designed to assess the effectiveness of the company's patented fully-automatic hospital bedside monitor-defibrillator, the Powerheart Cardiac Rhythm Module (CRM), against the traditional hospital "code blue" emergency response protocol.

Read More

DexCom Increases IPO Pricing

Venture-backed glucose monitoring systems maker DexCom has bumped up the value of its initial public offering (IPO) by 8 percent to $75.7 million.

Read More